Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed

Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project

(2012) C.A. Stiller et al.   EUROPEAN JOURNAL OF CANCER

Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1

(2012) Stefano Ferrari et al.   JOURNAL OF CLINICAL ONCOLOGY

Accumulating Evidence for a Drug-Drug Interaction Between Methotrexate and Proton Pump Inhibitors

(2012) S. Bezabeh et al.   ONCOLOGIST

Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors

(2011) Enrico P Spugnini et al.   Journal of Translational Medicine

Emerging drugs for high-grade osteosarcoma

(2010) Claudia Maria Hattinger et al.   EXPERT OPINION ON EMERGING DRUGS

Proton dynamics in cancer

(2010) Veronica Huber et al.   Journal of Translational Medicine

pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity

(2009) Angelo De Milito et al.   INTERNATIONAL JOURNAL OF CANCER